![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
Found 39 studies with search of: | "Deferasirox" |
Rank | Status | Study | ||||
---|---|---|---|---|---|---|
1 | Not yet recruiting |
Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to Food
|
||||
2 | Recruiting |
Iron Balance Study of Deferasirox, Deferoxamine and the Combination of Both
|
||||
3 | Active, not recruiting |
Pilot Study for Patients With Poor Response to Deferasirox
|
||||
4 | Recruiting |
Efficacy and Safety of Deferasirox in Non-Transfusion Dependent Thalassemia Patients With Iron Overload
|
||||
5 | Recruiting |
Pilot Trial of Deferasirox in the Treatment of Porphyria Cutanea Tarda
|
||||
6 | Completed |
Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
|
||||
7 | Active, not recruiting |
Extension Study on Efficacy and Safety of Deferasirox Treatment in Patients With Beta-Thalassemia and Transfusional Hemosiderosis
|
||||
8 | Completed |
Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload
|
||||
9 | Recruiting |
Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-Dependent Iron Overload
|
||||
10 | Recruiting |
Efficacy and Safety of Oral Deferasirox (20 mg/kg/Day) in Patients Three to Six Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron Overload
|
||||
11 | Recruiting |
ICL670 in Patients With Chronic Anemia and Transfusional Hemosiderosis
|
||||
12 | Active, not recruiting |
Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis
|
||||
13 | Recruiting |
Safety, Tolerability, and Efficacy of Deferasirox in MDS
|
||||
14 | Active, not recruiting |
Cardiac T2* in Beta-Thalassemia Patients on Deferasirox Treatment
|
||||
15 | Completed |
Effect of a Potent Inducer Rifampicin on the Pharmacokinetics of Deferasirox in Healthy Volunteers
|
||||
16 | Recruiting |
The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) Study
|
||||
17 | Recruiting |
Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron Overload
|
||||
18 | Recruiting |
ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With Deferasirox
|
||||
19 | Active, not recruiting |
Efficacy and Safety of Deferasirox in Patients With Transfusion-Dependent Iron Overload
|
||||
20 | Active, not recruiting |
An Extension Study of Iron Chelation Therapy With Deferasirox in β-Thalassemia Patients With Transfusional Iron Overload
|
![]() |
Previous Page | Studies Shown (1-20) | Next Page (21-39) |
![]() |